Critical Care Medicine Department,
Clinical Center,
Critical Care Medicine Department, Clinical Center
Yvonne Fitz has not added Biography.
If you are Yvonne Fitz and would like to personalize this page please email our Author Liaison for assistance.
Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.
American journal of respiratory and critical care medicine Nov, 2002 | Pubmed ID: 12403688
TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats.
Cytokine Nov, 2003 | Pubmed ID: 14572790
Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats.
American journal of physiology. Regulatory, integrative and comparative physiology Apr, 2004 | Pubmed ID: 14715494
Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model.
Journal of applied physiology (Bethesda, Md. : 1985) Oct, 2004 | Pubmed ID: 15169752
Granulocyte colony-stimulating factor has differing effects comparing intravascular versus extravascular models of sepsis.
The Journal of trauma Sep, 2004 | Pubmed ID: 15454812
Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
The Journal of infectious diseases Feb, 2005 | Pubmed ID: 15633102
Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model.
Journal of applied physiology (Bethesda, Md. : 1985) Jun, 2005 | Pubmed ID: 15677732
Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection.
The Journal of infectious diseases Mar, 2006 | Pubmed ID: 16453258
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival.
The Journal of infectious diseases Mar, 2006 | Pubmed ID: 16479518
Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.
Cytokine Mar, 2006 | Pubmed ID: 16720096
DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats.
Intensive care medicine Aug, 2006 | Pubmed ID: 16775718
Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.
The Journal of infectious diseases Feb, 2007 | Pubmed ID: 17230417
Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model.
Critical care medicine Jun, 2007 | Pubmed ID: 17452924
Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.
Intensive care medicine Mar, 2008 | Pubmed ID: 17992512
Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged mice.
Critical care medicine Apr, 2008 | Pubmed ID: 18176313
Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats.
Critical care medicine Apr, 2009 | Pubmed ID: 19242337
Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model.
Intensive care medicine Jan, 2010 | Pubmed ID: 19756496
SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice.
The Journal of trauma Jun, 2010 | Pubmed ID: 20068480
Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.
American journal of physiology. Heart and circulatory physiology Mar, 2011 | Pubmed ID: 21217068
The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.
Critical care medicine May, 2011 | Pubmed ID: 21317646
Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.
Critical care medicine Jun, 2011 | Pubmed ID: 21336113
The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model.
Intensive care medicine Oct, 2011 | Pubmed ID: 21922303
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.
American journal of physiology. Heart and circulatory physiology Jul, 2013 | Pubmed ID: 23585140
Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.
The Journal of infectious diseases Sep, 2013 | Pubmed ID: 23737601
Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat model.
Critical care (London, England) , 2014 | Pubmed ID: 24989885
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved